Dental Software Market – Product Development is the best strategy for market position; Forecast till 2023

 Dental Software Market Analysis

The global dental software market can reach a valuation of USD 4,185.5 billion by 2027. It is predicted to expand at a CAGR of 8% over the forecast period. Technological advances in dental imaging and the large geriatric populace are two of the biggest drivers of the market. According to the UNFPA, the geriatric population can reach a number of 1.3 billion by 2050. In addition, their low immunity makes them vulnerable to oral health diseases.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/675

Rise of dental surgeries, adoption of digital dental radiography systems, and advances in dental equipment can fuel the demand for dental software. Moreover, the large number of dentists and dental clinics can drive the demand for software for tracking appointments and providing prime customer service. Efficiencies in dental operations and use of intraoral cameras to gain accurate images of the mouth can bode well for the market.

High prices of digital dental system and complexities in the operation of the system can impede the market growth.

Dental Software Market Segmentation

The global dental software market has been segmented into type, application, and deployment.

Based on type, the market has been segmented into patient education software, practice management software, treatment planning software, patient communication software, and dental imaging software.

Major applications of the market are clinical application and administrative.

Based on deployment, the market is divided into on-premise model and web-based/cloud-based model.

Dental Software Market Regional Analysis

Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions taken into consideration with respect to the global dental software market.

The Americas held the largest market share owing to government support in assisting the dental industry in thriving. The U.S. held a share of 88% in North America in 2015. Large numbers of orthodontists and dental clinics can create demand for dental software.

Europe can showcase substantial growth in the market owing to awareness of the benefits of oral health and various options for cosmetic dentistry. APAC, on the other hand, can grow at a rapid pace owing to a plethora of opportunities for dental software in countries such as Japan and others.

Dental Software Market Competition Outlook

Planmeca oy, Datacon Dental Systems, Open Dental Software Inc., Ace Dental Software, Sirona Dental Systems, Inc., Dentimax LLC, Abeldent Inc., Carestream Health, Inc., Consult-pro, Henry Schein, Inc., Medicloud, Patterson Dental, Dexis, LLC, Imageworks Corporation, and Gendex Dental System are key players of the global dental software market.

Dental Software Industry News

A new software has been developed for the easy detection of the mandibular canal, a canal located in both sides of the jaw. Artificial intelligence has been integrated into the software for easy detection by scientists at the Finnish Center for Artificial Intelligence and Alan Turing Institute by training the software to recognize it by feeding 3D cone beam CT data scans.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/global-dental-software-market-675 

Global Dental Implants Market is Expected to Experience Immense Growth During 2020 – 2023

 Global Dental Implants Market is expected to register a CAGR of 4.6%and is anticipated to reach USD 6229.8 million by 2023.

Dental implant is the option for those people who have lost their tooth or teeth, owing to an injury, periodontal disease or some other reasons. It is an artificial tooth root that allow dentist to mount the replacement of teeth, by placing it into the jaw.  The dental implant is a metal post made up of titanium which help in surgeries beneath the gums. According to a report published by the Centers for Disease Control and Prevention, in 2015, around 84.7% of children aged 2-17 years, have visited dentist for checkup, and more than 62.7% of adults aged above 65 years have visited  dentist for dental implants.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2753 

Global Dental implants Market – Overview

The global dental implants market is rising with a swift phase; mainly owing to increase in patient population. According to the World Health Organization (WHO), in 2014, around 30% of the older aged (65-74) population globally have lost their natural teeth, around 60-90% of the school children globally and nearly 100% of the adults were believed to have dental cavities, about 15-20% middle aged (35-44 years) adults have found to have severe periodontal disease. Increasing consumer awareness about technology associated with oral health and rapidly increasing population globally leads to the growth of the dental implant market. Dentistry as a branch of healthcare has also further expanded and developed in its sub branches resulting in specialist oral care depending upon the type of treatment required for the oral care. Major specializations are orthodontics, endodontics, prosthodontics, and periodontics

Companies are continuously inventing in new products to capture the market globally. Thus, major players invest more in research and development activities, in order to lead the global market. In this regards, Osstem Implant, in 2015, invested in research and development to push for invention in the field of dental implants and persistently develops state-of-the-art products and thus, becoming the leader and the ‘First Mover’ in global dental implant market. Osstem Implant is also focusing on the expansion of sales network globally, advancement in education programs, and strategies for marketing.

In 2016, Zimmer Biomet dental division has introduce new technology of dental implants, and there surgical and restorative components. The company introduce 3.1-mmD Eztetic implant, which add-on improvement on existing available implants. According to the company, this product achieved a 43% higher fatigue strength in comparison to selected competitive implants of similar technical features. Increasing in genetic population globally and consumption of tobacco are the factors that leads the market of dental implants. Moreover companies are more focus to capture the market.

Competitive Analysis

Institut Straumann AG (Switzerland), 3M (U.S.), Osstem Implant (South Korea), Nobel Biocare (Part of Danaher corporation (U.S.), Dentsply Sirona (U.S.), Zimmer Biomet (U.S.), CAMLOG Biotechnologies AG (Switzerland), Neobiotech Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of dental implants, globally.

Global Dental Implants Market   – Regional Analysis

The market of dental implants is much higher in the Americas region. There are huge population which are missing all their teeth in one or both jaws. According to a report published in 2014, by the National Institute of Dental and Craniofacial Research, government initiated the National Oral Health Plan to improve the quality of life of the Americans. Through this program they were focusing on change in public perceptions, change in policymakers’ perceptions, and change in health providers’ perceptions.

Europe is also considered a huge market for dental implants players, owing to presence of huge population affected with oral diseases. Governments are more focusing on educating their public in order to minimize the patient’s population by educating them about the relationship between mouth and rest of the body.

Asia Pacific and the Middle East and Africa region are considered untapped markets. Whereas, country like India and China of Asia Pacific region are considered as the fastest growing region due to presence of huge population suffering with oral health issues. Japan is well developed country and have well established healthcare system and technology, whereas developing countries are still focusing on new drugs and technology for the treatment of dental implants, this gap between the developed and developing countries will present significant growth opportunity for the dental implants market players in the coming years. Additionally, they are open to adopt new technology and best treatment option from developed countries in order to improve the quality of life for their public. Whereas, the Middle East and Africa are low growth market due to lack of investment.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dental-implants-market-2753 

AR & VR in Healthcare Market – A market with high CAGR and return on investment by 2023

 

Market Highlights

The AR & VR in healthcare market is expected to grow at an approximate CAGR of 30.2% during forecast period, 2018–2023.

Rising demand to reduce healthcare cost is one of the key factors driving the AR & VR in healthcare market. For instance, with the use of AR navigation system nearly USD 288 million can be saved on minimally-invasive surgical procedures in the US.

Various other factors such as rising government funding, high prevalence of chronic diseases, rising adoption of AR and VR in fitness management, increasing penetration of connected devices in the healthcare sector, and rising awareness about VR therapy are also expected to propel the growth of the market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7208 

However, concerns regarding data privacy, lack of expertise among medical practitioners, and lack of competence in deployment of the AR and VR solutions can hinder the market growth over the forecast period.

Segmentation

The AR & VR in healthcare market is segmented based on technology, offering, device type, application, end user, and region.

The global market for AR & VR in healthcare, by technology is segmented into AR technology and VR technology. The AR technology segment is further classified as marker-based AR and markerless AR. The marker-based AR segment includes passive marker, and active marker. The markerless AR segment includes model-based tracking, and image processing-based tracking. The VR technology segment is further classified as nonimmersive technology, and semi-immersive and fully immersive technologies.

Based on offering, the market is segmented into hardware components and software. The hardware components segment is further classified as sensors, semiconductor component, displays and projectors, position tracker, cameras, and others. The sensors segment includes accelerometer, gyroscope, magnetometer, and proximity sensor. The semiconductor component segment includes controller/processor, and integrated circuits. The software segment is further classified as software development kits, and cloud-based services.

Based on device type, the market is segmented into AR device type, and VR device type. The AR device type segment is further classified as head-mounted display, and handheld device. The VR device type segment is further classified as head-mounted display, gesture-tracking device, and projectors and display walls. The gesture-tracking device segment includes data gloves, and others.

Based on application, the market is segmented into fitness management, patient care management, surgery, pharmacy management, medical training and education, and others.

Based on end user, the market is segmented into hospitals & clinics, surgical centres, pharmaceutical companies, research and academic institutes, and others.

Regional Analysis

The Americas dominated the global market for AR & VR in healthcare owing to the rising demand to reduce healthcare cost and presence of major market players.

In 2017, it was estimated that Europe stood second in the AR & VR in healthcare market. This can be attributed to the rising funding for innovation and increasing technological advancements. For instance, the European Union’s Horizon 2020 programme is allocating nearly USD 91.51 billion of funding over seven years for research and innovation.

Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure and high prevalence of chronic diseases drives the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the AR & VR in healthcare market due to the low per capita income and stringent government policies, especially within the African region.

Key Players

Some of the key players in the AR & VR in healthcare market are Atheer, Augmedix, Daqri, Firsthand Technology, Google, Medical Realities, Microsoft, Mindmaze, Oculus VR, Psious, EchoPixel, Inc., Osso VR Inc., SURGICAL THEATER, LLC, Orca Health, Inc., Hologic Inc., 3D Systems, Inc., and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/ar-vr-in-healthcare-market-7208 

Global Myelodysplastic Syndrome (MDS) Drugs Market is Expected to Experience Immense Growth During 2020 – 2025

 Market Highlights

The Global Myelodysplastic Syndrome (MDS) drugs market is expected to grow significantly over the forecast period. The Myelodysplastic Syndrome (MDS) drugs market held a valuation of USD 1,581.59 million in 2018 and is projected to register a CAGR of 10.1% over the forecast period.

The increasing participation of key players is one of the key factors driving the Myelodysplastic Syndrome (MDS) drugs market. In 2018, the US Food and Drug Administration approved generic injectable product decitabine for Lupin Ltd. There are various other MDS medications available in the market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/8134 

Various other factors that are driving the MDS drugs market are the promotion of clinical studies related to MDS, increasing geriatric population, rise in regulatory approvals, and growing participation of generic drugs manufactures.

However, the risk of infections during blood transfusions and side-effects of chemotherapy may hamper market growth over the forecast period.

Segmentation

The global Myelodysplastic Syndrome (MDS) drugs market is segmented based on product, type of syndrome, route of administration, end user, and region.

Based on product, the global Myelodysplastic Syndrome (MDS) drugs market is further segmented into chemotherapy, immunomodulatory drugs, and others. The chemotherapy segment is sub-segmented as conventional drugs and hypomethylating drugs. Hypomethylating drugs include Azacitidine and Decitabine. Conventional drugs comprise Cytarabine, Daunorubicin, and Idarubicin.

The MDS drugs market at a global level is segmented on type of syndrome into refractory cytopenia with multilineage dysplasia, refractory anemia, refractory anemia with excess blasts, refractory anemia with ringed sideroblasts, refractory cytopenia with multilineage dysplasia, and others.

Based on the route of administration, the market is segmented into oral, parenteral, and others. The MDS drugs available in the market are administered through parenteral route, for instance, intravenous or subcutaneous. The parental route has a quick effective after administration. Thus, the parenteral segments have greater growth compared to the other dosage forms in this segment. Based on end user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. MDS patients are treated in the hospitals, clinics, and ambulatory surgical centers. MDS drugs are prescribed by physicians to patients, as in critical conditions, it could lead to blood cancer. The hospitals segment holds the major share in this segment as it deals with a larger number of MDS patients compared to clinics and ambulatory surgical centers.

Key Players

Various players operate in the global Myelodysplastic Syndrome (MDS) Drugs market such as BluePoint Laboratories, Celgene Corporation, Celgene Europe Limited, Dr. Reddy’s Laboratories Inc., Johnson & Johnson, Lupin Ltd Corporation, Otsuka America Pharmaceutical Inc, Sandoz, Shilpa Medicare Limited, Sun Pharmaceutical Industries Inc, and others.

Regional Analysis

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The global MDS drugs market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European global MDS drugs market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The MDS drugs market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The global Myelodysplastic Syndrome drugs market in the Middle East & Africa has been segmented into the Middle East and Africa.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/myelodysplastic-syndrome-drugs-market-8134 

Global CAR T Cell Therapy Market Research Report 2020 Analysis and Forecast to 2025

 CAR T Cell Therapy Market Analysis

The CAR T cell therapy market size is predicted to touch USD 8716.06 million at a 58.52% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. CAR T cell therapy is amid the biggest breakthroughs and most promising treatment for cancer patients after chemotherapy. It is a form of immunotherapy where physicians gather immune cells from the patient, modify the same in the laboratory, and offer them the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. These infused cells multiply and remain in the patient’s body as living drugs. Short treatment time is one of the key benefits of CAR T cell therapy. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8102  

Numerous factors are adding to the CAR T cell therapy market demand. Such factors, as revealed by the latest MRFR report, include an increasing number of cell therapy clinical studies, growing pharmaceutical industry, technological advances for reliable and advanced treatment for cancer, and rising incidence of cancer both in adults & children worldwide. Additional factors adding to the CAR T cell therapy market growth include increasing initiatives by the government to promote cell therapy research in cancer and improve health care infrastructure and increasing approvals of CAR T cell therapies. 

On the contrary, high treatment costs and certain side effects that may cause CRS (cytokine release syndrome) and other forms of neurological problems, including delirium, hallucinations, coma, and seizures, are factors that may limit the CAR T cell therapy market growth over the forecast period. 

Market Segmentation

The Market Research Future’s CAR T cell therapy market report provides an inclusive segmental analysis of the CAR T cell therapy market on the basis of target antigen and application.

By target antigen, the CAR T cell therapy market has been segmented into CD22, CD19, & others. Among these, the CD19 target antigen segment will lead the market over the forecast period. It was valued USD 342.56 million in 2018. 

By application, the CAR T cell therapy market is segmented into diffuse large B-cell lymphoma, acute lymphoblastic leukemia, and others. Of these, diffuse large B-cell lymphoma will have a major share in the market over the forecast period. 

Regional Analysis 

By region, the global CAR T cell therapy market covers the growth opportunities and recent trends across Europe, the US, China, and the Rest of the World. Of these, the US will dominate the market over the forecast period for the rapid development along with the launch of novel therapies by top industry players to treat cancer, and huge patient pool suffering from cancer. 

The CAR T cell therapy market in Europe is predicted to hold the second-largest share over the forecast period for extensive research & rising investment to develop cancer therapies, and rising prevalence of hematologic cancer especially multiple myeloma, lymphoma, and leukemia. 

The CAR T cell therapy market in China is predicted to have significant growth over the forecast period for the increasing disposable income and developing healthcare infrastructure. Besides, the rising number of CAR T cell therapy market companies signing and collaborating research and manufacturing contracts with the region’s local players for these therapies are also adding market growth. Cesca Therapeutics, for instance, signed an agreement in March 2018 with Boyalife Group in China for CAR-T cell-related manufacturing outsourcing, development, and bioprocessing. 

The CAR T cell therapy market in the RoW is predicted to have stable growth over the forecast period.

Key Players

Eminent players profiled in the CAR T cell therapy market report include Mustang Bio (US), Sorrento Therapeutics (US), Legend Biotech (US), Juno Therapeutics (US), Autolus Therapeutics PLC (UK), CARsgen Therapeutics (China), Cellectis (France), Pfizer, Inc. (US), Kite Pharma (US), and Novartis AG (Switzerland).

Industry News

March 2020: Tessa Therapeutics’ CD30-targeted CAR T-cell therapy has received RMAT designation by US FDA to treat refractory or relapsed classical Hodgkins lymphoma. Its benefits comprise early detections together with sponsors. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/car-t-cell-therapy-market-8102  

Immunoprecipitation Market: Worldwide Industry Analysis and New Market Opportunities Explored

 Market Highlights

It is estimated that the global immunoprecipitation market is expected to hold a market value of USD 562 million and register a CAGR ~ 5.2% during the forecast period of 2018–2023. The method of precipitating a protein antigen from a solution by using an antibody that exactly binds to that particular protein is known as immunoprecipitation. This technique can be used for isolation and concentration of a particular protein from a sample that contains thousands of different proteins. A growing number of research activities in the life sciences sector and rising need to identify antigens associated with autoimmune diseases are driving the market growth. According to a report published by the British Society of Immunology in March 2016, more than 80 autoimmune diseases have been identified. Furthermore, increasing investments by governments and industries, rising biotechnology research across the globe, and growing awareness about personalized therapeutics is fueling the market growth.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7816 

However, the presence of alternative technologies for protein purification may negatively affect market growth during the forecast period.

The global immunoprecipitation market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in January 2018, Abcam plc entered into a strategic agreement with F. Hoffmann-La Roche Ltd, a leading biotech company, under which Abcam received the exclusive rights to the product portfolio of Spring, that consists of 243 recombinant rabbit monoclonal antibodies and 500 additional antibody products. 

Regional Analysis

Americas is anticipated to dominate the global immunoprecipitation market owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the immunoprecipitation market in the region.

Europe is expected to hold the second largest position in the global immunoprecipitation market. The market growth in this region is attributed to the availability of funds for research.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the growing investment from governments, growing biotechnology research in these regions, and raising awareness about personalized therapeutics.

On the other hand, the Middle East & Africa is expected to account for the least share of the market.

Segmentation

The global immunoprecipitation market has been segmented into type, product, end-user, and region.

The market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.

The market, by type, has been segmented into kit, reagent, and others.

The market, based on reagent, has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.

The market, by end-user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.

Key Players

Some of the key players in the global immunoprecipitation market are Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Merck KGaA, BioLegend, Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology, Inc., Geno Technology Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/immunoprecipitation-market-7816 

Dental Industry Market: Detailed Segmentation and Forecast 2023

 Dental Industry Market Analysis 

The global dental industry market is likely to grow at a 7.6% CAGR between 2018- 2023, as per the new report by Market Research Future (MRFR). The dental industry market comprises instruments, devices, treatment, and diagnosis associated with oral health. There are numerous problems related to oral health like discoloration or brown color in teeth, teeth cavity, pigmentation in gums, and others that are treated under the dental industry market.  

Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Dental Industry Market @ https://www.marketresearchfuture.com/sample_request/7637

Various factors are adding to the global dental industry market growth. Such factors, according to the new MRFR report, include rising geriatric population, the inclusion of 3D technology, increasing per capita income, better technological support, and rising cases of oral disease. Besides, demand for various dental procedures, rising prevalence of gum disease and oral cavity cancer & gum diseases, rise in technology, increasing awareness about oral health, consumers rising disposable income, changing lifestyles, and participation of health insurer reimbursements are also adding market growth. 

On the contrary, low dental insurance coverage may limit the dental industry market growth over the forecast period.  

Dental Industry Market Segmentation 

The MRFR report offers an inclusive segmental analysis of the global dental industry market report based on end users, discipline, and consumables. 

By discipline, the global dental industry market is segmented into oral surgery, prosthodontics, orthodontics, restorative dentistry, endodontics, and periodontics.  

By consumables, the dental industry market is segmented into endodontic supplies, dental anesthetic, dental syringe, dental biomaterial, gingival retraction material, dental burs, and whitening material. Dental biomaterial is again segmented into regenerative tissue material, dental cement, and dental bone graft. Gingival retraction material is again segmented into gingival retraction cap/gels/paste, gingival hemostatic agents, and gingival retraction cord. Dental anesthetic is again segmented into non-injectable anesthetic, topical anesthetics, and injectable anesthetic. Dental syringe is again segmented into non-disposable syringes and safety syringes/disposable syringes. Endodontic supplies are again segmented into cement and files.  

By end user, the dental industry market is segmented into research institutes, dental hospitals and clinics, and dental institutes and dental academics.  

Dental Industry Market Regional Analysis 

Based on the region, the dental industry market report covers the recent trends & growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period for a huge patient pool having different oral issues, presence of several market players, and demand for cosmetic surgery. Additional factors adding market growth include easy inclusion of technologies, infrastructural backing, and better scope for investment. Canada & the US are the chief contributors in the region for the rising number of patients needing help from dentists.  

The dental industry market in Europe is predicted to hold the second-largest share over the forecast period. Factors adding to the dental industry market growth in the region include gum problems, increasing tobacco consumption, and rising geriatric population. Besides, technological inclusion, better investment capacity, and Hungary being the dental tourism hub are also adding market growth.  

The dental industry market in the APAC region is predicted to grow at the fastest pace over the forecast period for the changes in infrastructure and rising investments in the healthcare sector. Australia, Japan, India, and China are the chief contributors in the region.  

The dental industry market in the MEA is predicted to have slow growth over the forecast period for the presence of countries that are economically poor. 

Dental Industry Market Competitive Landscape 

Leading players profiled in the global dental industry market report include Biomet, Zimmer Kangda Medical, 3M Company, Ultradent Products Inc., Young Innovations Inc., Patterson Companies Inc., Dentsply Sirona, Ivoclar Vivadent AG, Nakanishi Inc., Henry Schein Inc., and Hu-Friedy Mfg Co. Industry players have incorporated several strategies to stay ahead in the competition, such as geographic locations, mergers and acquisitions, expansions, joint ventures and collaborations, new product launch and development, contracts, and extensive R&D. 

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-industry-market-7637